| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |